Clinics in Dermatology
Volume 26, Issue 1 , Pages 4-11 , January 2008

Probiotics and the skin

  • Giuseppe Caramia

      Affiliations

    • Pediatric Department, Salesi Hospital, Ancona, Italy
    • ,
  • Alessandra Atzei

      Affiliations

    • Neonatal Intensive Care Unit, Neonatal Pathology and Neonatal Section, University of Cagliari, Italy
    • ,
  • Vassilios Fanos

      Affiliations

    • Neonatal Intensive Care Unit, Neonatal Pathology and Neonatal Section, University of Cagliari, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0706093426; fax: +39 0706093430.

References 

  1. Metchnikoff E. In: The prolongation of life. New York: Putman and Sons; 1907;p. 1–38
  2. Lilly DM, Stillwell RH. Probiotics: growth promoting factors produced by microorganisms. Science. 1965;147:747–748
  3. Grunlund MM, Lehtonen OP, Eerola E, et al. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after Caesarean delivery. J Pediatr Gastroenterol Nutr. 1999;28:19–25
  4. Mattila-Sandholm T, Blum S. Probiotics: towards demonstrating efficacy. Trends Food Sci Technol. 1999;10:393–399
  5. Harmsen HG, Wildeboer-Veloo AC, Roangs GC, et al. Analysis of intestinal flora development in breast-fed infant by using molecular identifications and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61–67
  6. Probert HM, Gibson GR. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol. 2002;3:23–27
  7. Gebbers JO, Laissue JA. Postnatal immunomorphology of the gut. In:  Hadziselimovc F,  Herzog B,  Burgin-Wolff A editor. Inflammatory bowel disease and coeliac disease in children. Dordrecht: Academic Publishers; 1990;p. 3–44
  8. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut?. Trends Microbiol. 2004;12:562–568
  9. Sepp E, Julge K, Vasar M, et al. Intestinal microflora of Estonian and Swedish infants. Acta Pediatr. 1997;86:956–961
  10. Blum S, Delneste Y, Donnet A, et al. The influence of probiotic organisms on the immune response. Nutr Immunol Princ Pract. 2000;1:451–455
  11. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol. 2001;2:27–42
  12. Kramer MS, Guo T, Platt RW, et al. Does previous infection protect against atopic eczema and recurrent wheeze in infancy?. Clin Exp Allergy. 2004;34:753–756
  13. Benn CS, Melbye M, Wohlfahrt J, et al. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ. 2004;328:223
  14. Zutavern A, Hirsch T, Leupold W, et al. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy. 2005;35:1301–1308
  15. Rautava S, Ruuskanen O, Ouwehand A, et al. The hygiene hypothesis of atopic disease—an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378–388
  16. Alm JS, et al. An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr Allergy Immunol. 2002;3:402–411
  17. Schmidt WP. Model of the epidemic of childhood atopy. Med Sci Monit. 2004;10:HY5–HY9
  18. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the ehygiene hypothesisf: too clean to be true?. Br J Dermatol. 2005;152:202–216
  19. Halken S. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr Allergy Immunol. 2004;4-5(15 Supp 16):9–32
  20. Noverr MC, Noggle RM, Toews GB, et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun. 2004;72:4996–5003
  21. Noverr MC, Falkowski N, McDonald RA, et al. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005;73:30–38
  22. Macpherson AJ, Harris NL. Opinion: interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4:478–485
  23. Xu J, Chiang HC, Bjursell MK, et al. Message from a human gut symbiont: sensitivity is a prerequisite for sharing. Trends Microbiol. 2004;12:21–28
  24. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol. 2004;12:129–134
  25. Renz H, Blumer N, Virna S, et al. The immunological basis of the hygiene hypothesis. Chem Immunol Allergy. 2006;91:30–48
  26. Floistrup H, Swartz J, Bergstrom A, et al. Allergic disease and sensitization in Steiner school children. The Parsifal Study Group. J Allergy Clin Immunol. 2006;117:59–66
  27. Zutavern A, Brockow I, Schaaf B, et al. Timing of solid food introduction in relation to atopic dermatitis and atopic sensitization: results from a prospective birth cohort study. LISA Study Group. Pediatrics. 2006;117:401–411
  28. Russo M, Nahori MA, Lefort J, et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol. 2001;24:518–526
  29. Chung Y, Cho J, Chang YS, et al. Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology. 2002;206:408–423
  30. Akbari O, Stock P, De Kruyff RH, et al. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol. 2003;15:627–633
  31. Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol. 2003;3:405–412
  32. Noverr MC, Huffnagle GB. The emicroflora hypothesisf of allergic diseases. Clin Exp Allergy. 2005;35:1511–1520
  33. Yamanaka T, et al. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol. 2003;170:816–822
  34. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004;93:97–108
  35. Strid J, Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy. 2005;4:531–541
  36. Steinhoff M, Brzoska T, Luger TA. Keratinocytes in epidermal immune responses. Curr Opin Allergy Clin Immunol. 2001;1:469–476
  37. Pivarcsi A, Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep. 2005;5:284–290
  38. Maurer D, Stingl G. Langerhans cells. In:  Lotze MT,  Thomson AW editor. Dendritic cells. London: Academic Press; 2001;p. 35–50
  39. Strid J, Hourihane J, Kimber I, et al. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol. 2004;34:2100–2109
  40. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol. 1998;28:769–779
  41. Wang LF, Lin JY, Hsieh KH, et al. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol. 1996;156:4077–4082
  42. Herrick CA, MacLeod H, Glusac E, et al. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest. 2000;105:765–775
  43. Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature. 2003;424:88–93
  44. Johansson-Lindbom BM, Svensson MA, Wurbel B, et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med. 2003;198:963–969
  45. Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol. 2004;172:857–863
  46. Mora JR, Cheng G, Picarella D, et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. JEM. 2005;201:3003–3016
  47. Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol. 2001;22:372–377
  48. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science. 2002;296:490–494
  49. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001;357:1093–1094
  50. Sheikh A, Smeeth L, Hubbard R. There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J Allergy Clin Immunol. 2003;111:131–135
  51. Miraglia del Giudice M, de Luca MG, et al. Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Digest Liver Dis. 2002;34:S68–S71
  52. Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology?. Best Pract Res Clin Gastroenterol. 2003;17:711–724
  53. Miraglia del Giudice M, De Luca MG. The role of probiotics in the clinical management of food allergy and atopic dermatitis. J Clin Gastroenterol. 2004;38(6 Suppl):S84–S85
  54. Ogden NS, Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr Opin Allergy Clin Immunol. 2005;5:179–184
  55. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179–185
  56. Kunz B, Oranje AP, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195:10–19
  57. Isolauri E, Arvola T, Sutäs Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604–1610
  58. Pessi T, Sutäs Y, Hurme M, et al. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000;30:1804–1808
  59. Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. JACI. 2002;109–121
  60. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076–1079
  61. Kalliomäki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: r-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–1871
  62. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111:389–395
  63. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003;36:223–227
  64. Hattori K, Yamamoto A, Sasai M, et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi. 2003;52:20–30
  65. Pohjavuori E, Viljanen M, Korpela R, et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol. 2004;114:131–136
  66. Viljanen M, Kuitunen M, Haahtela T, et al. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol. 2005;16:65–71
  67. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60:494–500
  68. Weston S, Halbert A, Richmond P, et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005;90:892–897
  69. Szajewska H. Probiotics for treatment and prevention of allergic disease. What is the evidence? Atti Congresso Milanopediatria Workshop Alimentazione e Immunità Milano 11-13 Novembre 2004; 8-11.
  70. Prescott SL, Tang ML. The Australasian Society of Clinical Immunology and Allergy position statement: summary of allergy prevention in children. Med J Aust. 2005;182:464–467
  71. Cross ML. Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Appl Immunol Rev. 2002;3:115–125
  72. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223–246
  73. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002;168:171–178
  74. Smits HH, Engering A, van der Kleij D, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3–grabbing nonintegrin. J Allergy Clin Immunol. 2005;115:1260–1267
  75. Prescott SL, Dunstan JA, Hale J, et al. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy. 2005;35:1557–1564
  76. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004;38:62–69
  77. De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005;24:278–280
  78. Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115:178–181
  79. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:35–44

PII: S0738-081X(07)00213-1

doi: 10.1016/j.clindermatol.2007.10.008

Clinics in Dermatology
Volume 26, Issue 1 , Pages 4-11 , January 2008

Article Tools